Monitoring Bristol-Myers Squibb Co (BMY) after recent insider movements

Bristol-Myers Squibb Co’s recent filing unveils that its President, RayzeBio Org. Hickey Benjamin unloaded Company’s shares for reported $3702.0 on May 09 ’25. In the deal valued at $38.01 per share,97 shares were sold. As a result of this transaction, Hickey Benjamin now holds 0 shares worth roughly $0.0.

Then, Hirawat Samit bought 4,250 shares, generating $202,215 in total proceeds. Upon buying the shares at $47.58, the EVP,Chief Med.Offr.,Drug Dev. now owns 83,513 shares.

Before that, BOERNER CHRISTOPHER S. bought 2,000 shares. Bristol-Myers Squibb Co shares valued at $110,096 were divested by the Chief Executive Officer at a price of $55.05 per share. As a result of the transaction, BOERNER CHRISTOPHER S. now holds 104,626 shares, worth roughly $4.91 million.

Piper Sandler initiated its Bristol-Myers Squibb Co [BMY] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”a Neutral”‘ rating. Jefferies also remained covering BMY and has increased its forecast on December 16, 2024 with a “Buy” recommendation from previously “Hold” rating.

Price Performance Review of BMY

On Monday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock jump 0.13%% to $46.92. Over the last five days, the stock has lost -5.69%. Bristol-Myers Squibb Co shares have risen nearly 14.97% since the year began. Nevertheless, the stocks have fallen -17.04% over the past one year. While a 52-week high of $63.33 was reached on 03/11/25, a 52-week low of $39.35 was recorded on 05/14/25.

Levels Of Support And Resistance For BMY Stock

The 24-hour chart illustrates a support level at 46.43, which if violated will result in even more drops to 45.94. On the upside, there is a resistance level at 47.29. A further resistance level may holdings at 47.67.

How much short interest is there in Bristol-Myers Squibb Co?

A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-05-30, dropping by -4.58 million shares to a total of 32.54 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 37.12 million shares. There was a decline of -14.07%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on November 15, 2024 when Wolfe Research began covering the stock and recommended ‘”a Peer perform”‘ rating .

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.